Precision medicine and data
Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directoryGuardant InfinityAI medical AI product profile
Guardant Health AI and machine-learning portfolio for precision oncology data and multimodal real-world evidence workflows.
Precision medicine and data
Best fit
Organizations exploring clinical-genomic oncology cohorts, biomarker hypotheses, testing value, and longitudinal cancer data strategy.
- Primary use case
- AI-enabled precision oncology data exploration, cohort analysis, molecular pattern discovery, and real-world evidence workflows
- Audience
- Precision oncology, biopharma, research, real-world evidence, and clinical-genomic data teams
- Risk level
- High
- Pricing signal
- Enterprise and partner pricing; request current terms.
- Official sources
- 3 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Guardant InfinityAI as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Separate exploratory cohort analytics, biomarker discovery, testing-value analysis, and any patient-specific use because each can carry different clinical, regulatory, or submission expectations. |
|---|---|
| Privacy | Review consent, de-identification, data-use agreements, partner access, longitudinal clinical-genomic linkage, and any customer-data upload before using oncology datasets. |
| Evidence | Check data provenance, completeness, cohort definitions, molecular-pattern methods, external validation, and whether insights are hypotheses, real-world evidence, or clinically actionable findings. |
| Workflow | Use with oncology, bioinformatics, regulatory, privacy, and commercial review paths before applying outputs to trials, testing strategy, or patient-care workflows. |
Where Guardant InfinityAI fits
Guardant Health describes InfinityAI as purpose-built AI and machine learning for precision oncology, including multimodal data foundations, self-service cohort exploration, molecular pattern analysis, and real-world clinical-genomic data products.
Not for: Direct patient treatment selection without oncologist review, assay-specific clinical validation, and governance over real-world data use.
What to verify before using Guardant InfinityAI
- Which InfinityAI module, data library, or Guardant product feature is being evaluated.
- Whether the workflow is research, biopharma analytics, clinical operations, or patient-specific decision support.
- Data provenance, consent, de-identification, longitudinal completeness, and genomic test coverage.
- How AI-generated cohort insights, molecular patterns, and hypotheses are reviewed before clinical or commercial use.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- guardanthealth.com / products / infinityai
- investors.guardanthealth.com / press-releases / press-releases
- investors.guardanthealth.com / press-releases / press-releases
Related medical AI products
Precision medicine and data
Anumana ECG-AI
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
Precision medicine and data
Eko Health SENSORA
FDA-cleared cardiovascular detection platform that pairs Eko digital stethoscopes with AI-supported ECG and heart-sound analysis for supervised point-of-care screening.
Precision medicine and data
AliveCor Kardia 12L
Portable AI-powered 12-lead ECG system that uses a reduced leadset and KAI 12L algorithms to support clinician-reviewed cardiac determinations.